|
FNIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.176000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.082300E-03 |
| Normal-vs-Stage2 |
3.795800E-01 |
| Normal-vs-Stage3 |
5.544200E-01 |
| Normal-vs-Stage4 |
1.955050E-03 |
| Stage1-vs-Stage2 |
2.094800E-01 |
| Stage1-vs-Stage3 |
2.134600E-01 |
| Stage1-vs-Stage4 |
1.199640E-01 |
| Stage2-vs-Stage3 |
8.870600E-01 |
| Stage2-vs-Stage4 |
4.887800E-02 |
| Stage3-vs-Stage4 |
4.161800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.443900E-03 |
| Normal-vs-AfricanAmerican |
7.495200E-03 |
| Normal-vs-Asian |
4.439400E-01 |
| Caucasian-vs-AfricanAmerican |
7.518400E-01 |
| Caucasian-vs-Asian |
9.230600E-01 |
| AfricanAmerican-vs-Asian |
9.976800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.442100E-03 |
| Normal-vs-Female |
2.645400E-01 |
| Male-vs-Female |
1.799720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.216990E-01 |
| Normal-vs-Extreme_Weight |
4.20239999999739E-05 |
| Normal-vs-Obese |
1.174430E-01 |
| Normal-vs-Extreme_Obese |
1.597610E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.529190E-01 |
| Normal_Weight-vs-Obese |
7.667400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.380200E-01 |
| Extreme_Weight-vs-Obese |
2.018400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.809600E-01 |
| Obese-vs-Extreme_Obese |
7.732600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.384600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.906160E-02 |
| Normal-vs-Age(61-80Yrs) |
3.924200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.644400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.282400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.292000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.406200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.722000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.552600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.238200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.36459999999728E-05 |
| Normal-VS-Type2 PRCC |
8.188600E-01 |
| Normal-VS-KIRP CIMP |
2.023200E-01 |
| Normal-VS-Unclassified PRCC |
2.461800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.721320E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.848000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.644300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.358400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.197200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.233200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.972420E-01 |
| Normal-vs-N1 |
5.093700E-02 |
| Normal-vs-N2 |
4.034300E-02 |
| N0-vs-N1 |
5.448800E-01 |
| N0-vs-N2 |
4.156600E-01 |
| N1-vs-N2 |
5.173200E-01 |
|
|
